Profile
| Metric | Value |
|---|---|
| Full Name | Ventas, Inc. |
| Ticker | NYSE: VTR |
| Exchange | NYSE |
| Sector | Real Estate |
| Industry | Healthcare Facilities |
| Country | United States |
| IPO | |
| Indexes | |
| Website | ventasreit.com |
| Employees | 498 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $75.69 | |
| Price, 1D Change | -0.59% | |
| Market Cap | $36B | |
| TTM Dividend Yield | 2.54% | |
| PE Ratio | 143.05 | |
| Beta | 0.24 | |
| Revenue | $5B | |
| Revenue, 1Y Change | +9.98% | |
| EPS | $0.19 | |
| EPS, 1Y Change | +291.08% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | $0.48 | |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 8757:10000 | |
| Next Split | N/A | N/A |
| Last Ticker Change | VC | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | $0.19 | |
| EPS Estimate | $0.27 | |
| EPS Est. Change | +38.53% | |
| Revenue | $4.95B | |
| Revenue Estimate | $5.79B | |
| Revenue Est. Change | +17.04% | |
| Current Price | $75.69 | |
| Price Target | - | $85.00 |
| Price Tgt. Change | - | +12.30% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $0.00 | -$0.10 | +100.00% | |
| - | $0.19 | - | |
| $0.27 | N/A | +38.53% | |
| $0.57 | N/A | +189.89% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $4.46B | $4.50B | +0.82% | |
| $4.88B | $4.95B | +1.43% | |
| $5.79B | N/A | +17.04% | |
| $6.66B | N/A | +34.62% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | +32.63% | |
| Price, 3Y | +58.28% | |
| Market Cap, 1Y | +42.53% | |
| Market Cap, 3Y | +86.02% | |
| Revenue, 1Y | +9.98% | |
| Revenue, 3Y | +29.22% | |
| EPS, 1Y | +291.08% | |
| EPS, 3Y | +53.59% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $75.69 | |
| SMA 200 | $69.45 | |
| SMA 200 vs Price | -8.24% | |
| SMA 50 | $77.70 | |
| SMA 50 vs Price | +2.65% | |
| Beta | 0.24 | |
| ATR | $1.27 | |
| 14-Day RSI | 33.85 | |
| 10-Day Volatility | 11.51% | |
| 1-Year Volatility | 22.08% |
Dividends
| Metric | Date | Value |
|---|---|---|
| Last Paid | $0.48 | |
| Upcoming | N/A | N/A |
| Dividend Yield | 2.38% | |
| Total Dividend | $1.80 | |
| Dividends Paid | $740.33M | |
| Payout Ratio | 837.94% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $4.95B | |
| EPS | $0.19 | |
| Gross Profit | $918.65M | |
| Gross Margin | 18.57% | |
| Operating Profit | $706.25M | |
| Operating Margin | 14.28% | |
| Net Income | $88.35M | |
| Net Margin | 1.79% | |
| EBITDA | $1.87B |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 1.28 | |
| Current Ratio | 0.67 | |
| Quick Ratio | 0.67 | |
| Interest Coverage | 1.19 | |
| F-Score | 6 | |
| Altman Z-Score | 1.30 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | 143.05 | |
| PS Ratio | 6.40 | |
| PB Ratio | 2.88 | |
| EV/EBITDA | 22.97 | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $10.77B | |
| Cash & Equivalents | $957.23M | |
| Total Assets | $26.19B | |
| Current Assets | $1.29B | |
| Total Liabilities | $15.05B | |
| Current Liabilities | $1.93B | |
| Total Debt | $13.82B | |
| Short Term Debt | $1.81B | |
| Accounts Payable | - |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $4.87B | |
| Operating Expenses | $212.41M | |
| Cost Of Goods Sold | $4.03B | |
| SG&A | $0.00 | |
| D&A | $1.20B | |
| Interest Expense | $591.44M | |
| Income Tax | -$37.78M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | $1.34B | |
| CFI | -$2.39B | |
| CFF | $1.45B | |
| Capex | $281.61M | |
| Free Cash Flow | $1.06B |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Keybanc | → | |
| Wells Fargo | → | |
| Scotiabank | → | |
| Citigroup | → | |
| Cantor Fitzgerald | → | |
| Wells Fargo | → | |
| Cantor Fitzgerald | ||
| UBS | ||
| Evercore ISI Group | → | |
| Scotiabank | → |
Analyst sentiment
Institutional ownership
Screeners with VTR
Data Sources & References
- VTR Official Website www.ventasreit.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/740260/000074026025000277/0000740260-25-000277-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/740260/000074026025000052/0000740260-25-000052-index.htm
- List of S&P 500 Companies www.spglobal.com/spdji/en/indices/equity/sp-500/#overview
- VTR Profile on Yahoo Finance finance.yahoo.com/quote/VTR
- VTR Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/vtr
FAQ
What is the ticker symbol for Ventas, Inc.?
The ticker symbol for Ventas, Inc. is NYSE:VTR
Does Ventas, Inc. pay dividends?
Yes, Ventas, Inc. pays dividends. The last payment was $0.48, with an ex-dividend date on December 31, 2025
What sector is Ventas, Inc. in?
Ventas, Inc. is in the Real Estate sector
What industry is Ventas, Inc. in?
Ventas, Inc. is in the Healthcare Facilities industry
What country is Ventas, Inc. based in?
Ventas, Inc. is headquartered in United States
When did Ventas, Inc. go public?
Ventas, Inc. initial public offering (IPO) was on May 5, 1997
Is Ventas, Inc. in the S&P 500?
Yes, Ventas, Inc. is included in the S&P 500 index
Is Ventas, Inc. in the NASDAQ 100?
No, Ventas, Inc. is not included in the NASDAQ 100 index
Is Ventas, Inc. in the Dow Jones?
No, Ventas, Inc. is not included in the Dow Jones index
When was Ventas, Inc. last earnings report?
Ventas, Inc.'s most recent earnings report was on October 29, 2025
When does Ventas, Inc. report earnings?
The next expected earnings date for Ventas, Inc. is February 11, 2026
